ATE205084T1 - 2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer - Google Patents

2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer

Info

Publication number
ATE205084T1
ATE205084T1 AT92907890T AT92907890T ATE205084T1 AT E205084 T1 ATE205084 T1 AT E205084T1 AT 92907890 T AT92907890 T AT 92907890T AT 92907890 T AT92907890 T AT 92907890T AT E205084 T1 ATE205084 T1 AT E205084T1
Authority
AT
Austria
Prior art keywords
diaryl
dithiolanes
factor receptor
activating factor
receptor blocker
Prior art date
Application number
AT92907890T
Other languages
English (en)
Inventor
T Y Shen
David Goldstein
Diane M Gingrich
Original Assignee
Ct For Innovative Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct For Innovative Technology filed Critical Ct For Innovative Technology
Application granted granted Critical
Publication of ATE205084T1 publication Critical patent/ATE205084T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
AT92907890T 1991-03-04 1992-03-04 2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer ATE205084T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66455391A 1991-03-04 1991-03-04
PCT/US1992/001830 WO1992015294A1 (en) 1991-03-04 1992-03-04 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors

Publications (1)

Publication Number Publication Date
ATE205084T1 true ATE205084T1 (de) 2001-09-15

Family

ID=24666446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907890T ATE205084T1 (de) 1991-03-04 1992-03-04 2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer

Country Status (10)

Country Link
EP (1) EP0574510B1 (de)
JP (1) JP3216647B2 (de)
AT (1) ATE205084T1 (de)
AU (1) AU666844B2 (de)
CA (1) CA2104951A1 (de)
DE (1) DE69232046T2 (de)
DK (1) DK0574510T3 (de)
ES (1) ES2163399T3 (de)
HU (1) HUT65173A (de)
WO (1) WO1992015294A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
CA2140034A1 (en) 1992-07-13 1994-01-20 Xiong Cai 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
EP1094805A4 (de) 1998-07-03 2002-08-28 Millennium Pharm Inc Alicyclische verbindungen mit substituiertem sauerstoffatom, sowie deren bereitungsverfahren
CA2342156A1 (en) 1998-07-03 2000-01-13 Andappan Murugaiah Subbaiah Murugaiah Methods for synthesis of substituted tetrahydrofuran compound
US6255498B1 (en) 1998-10-16 2001-07-03 Millennium Pharmaceuticals, Inc. Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
CN1030415A (zh) * 1987-02-20 1989-01-18 山之内制药株式会社 饱和的杂环碳酰胺衍生物和它的制备方法
EP0365089A3 (de) * 1988-10-18 1991-06-05 Merck & Co. Inc. 2-Aryl-5(3-methoxy-5-(hydroxypropylsulfonyl)-4-propoxyphenyl)tetrahydrothiophen und Analoge

Also Published As

Publication number Publication date
JPH06507885A (ja) 1994-09-08
EP0574510A1 (de) 1993-12-22
DK0574510T3 (da) 2001-12-03
HUT65173A (en) 1994-05-02
HU9302491D0 (en) 1993-12-28
AU666844B2 (en) 1996-02-29
JP3216647B2 (ja) 2001-10-09
ES2163399T3 (es) 2002-02-01
EP0574510A4 (en) 1994-07-06
AU1533392A (en) 1992-10-06
EP0574510B1 (de) 2001-09-05
DE69232046D1 (en) 2001-10-11
WO1992015294A1 (en) 1992-09-17
DE69232046T2 (de) 2002-05-02
CA2104951A1 (en) 1992-09-05

Similar Documents

Publication Publication Date Title
FI943876A0 (fi) Heterobisykliset yhdisteet
DE69321461D1 (de) Desinfizierende zusammensetzung
ATE205084T1 (de) 2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer
BR9206577A (pt) Heteroalilaminas que atuam como novos inibidores de acetilcolinesterase
DK0531548T3 (da) Carbostyril-forbindelser som anti-thrombotiske midler
FI951009A (fi) Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä
DE69211675D1 (de) Ölzusammensetzungen
BR9300575A (pt) Maquina de cozinha
ATA18892A (de) Schubkastenauszug
DE69216194D1 (de) Plastisolzusammensetzungen
ITMI911285A0 (it) Composizioni disinfettanti polivalenti
BR9103183A (pt) Composicao desodorante
MX9204933A (es) Composiciones de poliester que contienen compuestos de fosfonio.
FI952803A (fi) Bentsatsepinonijohdannaiset
GB9423929D0 (en) Substituted benzene compounds as tranferase inhibitors
FI934033A0 (fi) Dubbelviraformer med lokalt staellbara draeneringslister
FI925354A (fi) Slam av vattenloesliga polymerer
ATA56693A (de) Wandschrankbett
FI944628A0 (fi) Kierrätettäviä vahapinnoitettuja laatikoita
ATA18992A (de) Schubladenauszug
ATA3194A (de) Schubladenauszug
KR920004656U (ko) 매립용 수도꼭지
ITRM920498A0 (it) Composizione per l'ignifugazione delle materie polimere.
ITCO910007V0 (it) Scatole profumate
KR940007133U (ko) 식기세척기의 악취 제거장치

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee